All In Biotech

Drug Trial Radar · NCT04373564

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor and Cognitive Functions in Neurologically Normal Adults in Comparison to a Non-GBCA Exposed Control Group

Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

2,076

Planned (sponsor's estimate)

Start

Mar 24, 2021

Primary completion

Dec 31, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
GuerbetIndustry
Sponsor type
Industry
Collaborators
Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)
First posted
May 4, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.

Conditions

  • Motor Function
  • Cognitive Function
  • Contrast Media

Interventions

  • Motor TestsProcedure

    To assess motor function annually

  • Cognitive TestsProcedure

    To assess cognitive function annually

  • Unenhanced-MRI of the brainProcedure

    The UE-MRI of the brain will be performed at baseline and at the year 5 visit in order to exclude presence of a significant MRI abnormality

  • Gadolinium MeasurementsProcedure

    Blood samples and spontaneous urine specimens will be collected through the course of the study to measure Gd concentration

  • Gadoxetate disodiumDrug

    Administered as defined by the treating physician as part of routine clinical practice

  • Gadobenate dimeglumineDrug

    Administered as defined by the treating physician as part of routine clinical practice

  • GadodiamideDrug

    Administered as defined by the treating physician as part of routine clinical practice

  • Gadoterate meglumineDrug

    Administered as defined by the treating physician as part of routine clinical practice

  • GadobutrolDrug

    Administered as defined by the treating physician as part of routine clinical practice

  • GadoteridolDrug

    Administered as defined by the treating physician as part of routine clinical practice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of motor function from baseline to year 5 in comparison to a matched non-GBCA-exposed control groupTime frame: At baseline, year 5
  2. Change in cognitive function from baseline to year 5 in comparison to a matched non-GBCA-exposed control groupTime frame: At baseline, year 5

Locations

51 sites in 8 countries. Site status is shown where the registry gives one.

  • Scottsdale Medical Imaging, LLC

    Scottsdale, Arizona · Recruiting

  • Yale University School of Medicine

    New Haven, Connecticut · Withdrawn

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • Methodist Medical Center of Illinois

    Peoria, Illinois · Recruiting

  • Massachussets General Hospital

    Boston, Massachusetts · Recruiting

  • Boston University Medical Center

    Boston, Massachusetts · Terminated

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Withdrawn

  • ActivMed Practices & Research, Inc.

    Methuen, Massachusetts · Withdrawn

  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts · Terminated

  • Department of Radiology

    St Louis, Missouri · Withdrawn

  • UNC School of Medicine

    Chapel Hill, North Carolina · Withdrawn

  • Penn State Hershey Medical Center

    Hershey, Pennsylvania · Recruiting

  • Albert Einstein Healthcare Network

    Philadelphia, Pennsylvania · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

  • MD Anderson Cancer Center

    Houston, Texas · Withdrawn

  • University of Wisconsin

    Madison, Wisconsin · Recruiting

  • CEMEC - Oncológica

    São Bernardo do Campo, Brazil · Withdrawn

  • Hospital Santa Marta

    Taguatinga, Federal District, Brazil · Terminated

  • Liga Norte-Rio-Grandense Contra o Câncer

    Natal, Rio Grande do Norte, Brazil · Withdrawn

  • Instituto Mederi de Pesquisa e Saude

    Passo Fundo, Rio Grande do Sul, Brazil · Recruiting

  • Hospital Moinhos de Vento

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Instituto Baía Sul de Ensino e Pesquisa (IEP)

    Florianópolis, Santa Catarina, Brazil · Withdrawn

  • CEMEC - Oncológica

    São Bernardo do Campo, São Paulo, Brazil · Withdrawn

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto

    São José do Rio Preto, São Paulo, Brazil · Recruiting

  • CPCLIN - Centro de Pesquisas Clínicas Ltda.

    São Paulo, São Paulo, Brazil · Terminated

  • Albert Einstein Sociedade Beneficente Israelita Brasileira

    São Paulo, São Paulo, Brazil · Recruiting

  • G. Kenneth Jansz Medical Professional Corporation

    Burlington, Ontario, Canada · Withdrawn

  • Groupe Hospitalier Pitie-Salpetriere

    Paris, France · Withdrawn

  • CHU Strasbourg - Hôpital Hautepierre

    Strasbourg, France · Recruiting

  • Vivantes Klinikum Neukoelln

    Berlin, Germany · Recruiting

  • Universitaetsklinikum Tuebingen

    Tübingen, Baden-Wurttemberg, Germany · Active not recruiting

  • Ospedale San Raffaele

    Milan, Italy · Recruiting

  • Università Campus Bio-Medico di Roma

    Roma, Italy · Recruiting

  • Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Roma)

    Verona, Italy · Recruiting

  • A.O.U. Senese Policlinico Santa Maria alle Scotte

    Siena, Siena, Italy · Recruiting

  • Azienda Ospedaliera Universitaria di Trieste

    Trieste, Trieste, Italy · Recruiting

  • BHI of Omsk region "Clinical Oncology Dispensary"

    Omsk, Russia · Suspended

  • FSBI "National medical scientific center of psychiatry and neurology n.a. V.M. Bekhterev" Adolescent

    Saint Petersburg, Russia · Suspended

  • FSBI North-West Federal Medical Research Center n.a. V.A. Almazov of MoH RF

    Saint Petersburg, Russia · Suspended

  • LLC Medical Center Mart

    Saint Petersburg, Russia · Suspended

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.